Business Description
Korean Drug Co Ltd
ISIN : KR7014570006
Compare
Compare
Traded in other countries / regions
014570.Korea IPO Date
2000-12-07Description
Korean Drug Co Ltd is engaged in manufacturing and marketing of pharmaceutical products in South Korea. Its products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 271.42 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 5235.45 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.98 | |||||
| Beneish M-Score | -2.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.1 | |||||
| 3-Year EBITDA Growth Rate | -1.6 | |||||
| 3-Year EPS without NRI Growth Rate | -25.1 | |||||
| 3-Year Book Growth Rate | 3.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.52 | |||||
| 9-Day RSI | 25.87 | |||||
| 14-Day RSI | 29.29 | |||||
| 6-1 Month Momentum % | -6.39 | |||||
| 12-1 Month Momentum % | -1.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.81 | |||||
| Quick Ratio | 3.43 | |||||
| Cash Ratio | 1.18 | |||||
| Days Inventory | 142.03 | |||||
| Days Sales Outstanding | 129.75 | |||||
| Days Payable | 34.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.51 | |||||
| Dividend Payout Ratio | 0.34 | |||||
| Forward Dividend Yield % | 2.51 | |||||
| 5-Year Yield-on-Cost % | 4.37 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 2.48 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.88 | |||||
| Operating Margin % | 22.23 | |||||
| Net Margin % | -6.6 | |||||
| FCF Margin % | -21.07 | |||||
| ROE % | -6.53 | |||||
| ROA % | -5.26 | |||||
| ROIC % | -20.6 | |||||
| ROC (Joel Greenblatt) % | 14.92 | |||||
| ROCE % | 9.01 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 13.67 | |||||
| Shiller PE Ratio | 11.54 | |||||
| PEG Ratio | 1.17 | |||||
| PS Ratio | 0.8 | |||||
| PB Ratio | 0.82 | |||||
| Price-to-Tangible-Book | 0.82 | |||||
| EV-to-EBIT | 6.22 | |||||
| EV-to-EBITDA | 4.98 | |||||
| EV-to-Revenue | 0.59 | |||||
| EV-to-FCF | -2.79 | |||||
| Price-to-Projected-FCF | 0.65 | |||||
| Price-to-DCF (Earnings Based) | 0.4 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.71 | |||||
| Price-to-Graham-Number | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 1.22 | |||||
| Earnings Yield (Greenblatt) % | 16.08 | |||||
| FCF Yield % | -26.3 | |||||
| Forward Rate of Return (Yacktman) % | 24.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korean Drug Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 80,541.413 | ||
| EPS (TTM) (â‚©) | -493 | ||
| Beta | 0.7 | ||
| Volatility % | 20.62 | ||
| 14-Day RSI | 29.29 | ||
| 14-Day ATR (â‚©) | 137.290829 | ||
| 20-Day SMA (â‚©) | 6224 | ||
| 12-1 Month Momentum % | -1.93 | ||
| 52-Week Range (â‚©) | 5870 - 7980 | ||
| Shares Outstanding (Mil) | 10.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korean Drug Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korean Drug Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korean Drug Co Ltd Frequently Asked Questions
What is Korean Drug Co Ltd(XKRX:014570)'s stock price today?
The current price of XKRX:014570 is â‚©5980.00. The 52 week high of XKRX:014570 is â‚©7980.00 and 52 week low is â‚©5870.00.
When is next earnings date of Korean Drug Co Ltd(XKRX:014570)?
The next earnings date of Korean Drug Co Ltd(XKRX:014570) is .
Does Korean Drug Co Ltd(XKRX:014570) pay dividends? If so, how much?
The Dividend Yield %  of Korean Drug Co Ltd(XKRX:014570) is 2.51% (As of Today), Highest Dividend Payout Ratio of Korean Drug Co Ltd(XKRX:014570) was 0.45. The lowest was 0.16. And the median was 0.25. The  Forward Dividend Yield % of Korean Drug Co Ltd(XKRX:014570) is 2.51%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers